Ursodeoxycholic acid in advanced polycystic liver disease: A phase 2 multicenter randomized controlled trial

scientific article published on 17 May 2016

Ursodeoxycholic acid in advanced polycystic liver disease: A phase 2 multicenter randomized controlled trial is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.JHEP.2016.05.009
P698PubMed publication ID27212247

P50authorJesus M BanalesQ64913476
P2093author name stringWietske Kievit
Luis Bujanda
Joost P H Drenth
Ulrich Beuers
R Bart Takkenberg
Myrte K Neijenhuis
Hedwig M A D'Agnolo
Ellen J L Brunenberg
Ioana Riaño
P433issue3
P921main subjectpolycystic liver diseaseQ246002
multicenter clinical trialQ6934595
phase II clinical trialQ42824440
P304page(s)601-607
P577publication date2016-05-17
P1433published inJournal of HepatologyQ15724402
P1476titleUrsodeoxycholic acid in advanced polycystic liver disease: A phase 2 multicenter randomized controlled trial
P478volume65

Reverse relations

cites work (P2860)
Q39186912An update on the pathophysiology and management of polycystic liver disease
Q92019794Autosomal dominant polycystic kidney disease
Q57298238Drug holiday in patients with polycystic liver disease treated with somatostatin analogues
Q92804537Estrogen-Containing Oral Contraceptives Are Associated With Polycystic Liver Disease Severity in Premenopausal Patients
Q50052506Impact of liver volume on polycystic liver disease-related symptoms and quality of life
Q64111335Long-term results of liver transplantation for polycystic liver disease: Single-center experience in China
Q90032067Management of portal hypertension and ascites in polycystic liver disease
Q90126279New synthetic conjugates of ursodeoxycholic acid inhibit cystogenesis in experimental models of polycystic liver disease
Q92532305Pathobiology of inherited biliary diseases: a roadmap to understand acquired liver diseases
Q99579325Review: Pathogenesis of cholestatic liver diseases

Search more.